// App-Quantinova.ai

3087 : Combination of ONC201 and bevacizumab significantly impacts colorectal cancer growth and metastasis in vivo

Researchers

Presenter

  • Jessica Wagner

Principal Investigators

  • Wafik S. El-Deiry

Medical Centers

  • Fox Chase Cancer Center: Temple College of Medicine, Philadelphia, PA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Colorectal Cancer

  • Unspecified Cancer

Biomarkers

  • TNF superfamily member 10

  • Vascular endothelial growth factor A

Drug/Treatment

  • Bevacizumab

  • TIC 10

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • I/II

Study Id's

  • NCT02324621

  • NCT02420795

  • NCT02392572

  • NCT02609230

  • NCT02525692

  • NCT02038699

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved